Summary: Safety is binary: you are either cleared or you are not. This checklist serves as a vital filter. Active cancer, pregnancy, and unstable heart conditions represent hard stops for most peptide protocols. Other conditions like diabetes or autoimmune history act as "yield" signs, requiring medical guidance to navigate safely. Always respect these biological boundaries; ignoring a contraindication is the fastest way to turn a health optimization protocol into a medical emergency.
Because peptides influence fundamental biological drivers—cell division, hormone secretion, and immune function—they can inadvertently act as fuel for underlying disease processes. This research article provides a comprehensive checklist of medical conditions that typically red-flag a patient. If you check any of these boxes, you must pause and consult a specialist before moving forward.
Absolute Contraindications (The “Stop” Signs)
These conditions generally disqualify an individual from most peptide protocols, particularly those involving growth factors or immune modulation.
- Active Malignancy (Cancer): This is the most critical rule. If you have active cancer, you must avoid Growth Hormone Secretagogues (GHS) like Ipamorelin, CJC-1295, or MK-677. You should also avoid angiogenic peptides like BPC-157. Increasing IGF-1 or blood vessel supply can theoretically accelerate tumor growth and metastasis.
- Pregnancy and Breastfeeding: There is virtually no safety data on the use of research peptides during pregnancy. Given that peptides can cross the placenta and influence fetal development (especially growth factors), they are strictly absolutely contraindicated. The risk of altering fetal developmental pathways is unknown and potentially catastrophic.
- Known Hypersensitivity: If you have had a severe allergic reaction (anaphylaxis) to a peptide or the carrier agents (like mannitol) in the past, re-exposure is dangerous.
- Proliferative Retinopathy: For diabetics with eye damage (retinopathy), increasing IGF-1 or growth factors can worsen the abnormal blood vessel growth in the eye, potentially threatening vision.
Cardiovascular Contraindications
Heart health is a major filter for safety. Many peptides cause water retention or shifts in electrolytes that the heart must manage.
- Congestive Heart Failure (CHF): Patients with CHF are extremely sensitive to fluid balance. Peptides that stimulate GH often cause transient water retention (edema). In a healthy person, this is annoying; in a CHF patient, it can precipitate a fluid overload crisis.
- Uncontrolled Hypertension: High blood pressure that is not managed by medication is a relative contraindication. Some peptides can acutely raise blood pressure or heart rate.
- Recent Myocardial Infarction (Heart Attack): In the immediate post-heart attack window (3-6 months), the body is in a delicate state of repair and scarring. Interfering with this process via experimental signaling agents is generally advised against unless part of a specific clinical trial.
Endocrine and Metabolic Contraindications
Since many peptides act on the endocrine system, existing hormonal disorders can create complex interactions.
- Pituitary Disorders: If you have a pituitary adenoma (tumor) or history of pituitary surgery, stimulating this gland with secretagogues is contraindicated. You do not want to stimulate potentially abnormal tissue.
- Uncontrolled Diabetes: While some peptides help insulin sensitivity, GH secretagogues can temporarily increase insulin resistance and raise blood glucose. For a diabetic with poor control, this can lead to dangerous hyperglycemia.
- Hypercortisolism (Cushing’s): Adding metabolic stimulants to a system already flooded with cortisol can exacerbate symptoms of anxiety, insomnia, and catabolism.
Relative Contraindications (Proceed with Caution)
These conditions do not strictly forbid use but require “eyes wide open” risk management and doctor supervision.
- Autoimmune Conditions: Peptides like Thymosin Alpha-1 are often used for autoimmunity, but immune modulators can be unpredictable. In some cases, “boosting” the immune system might flare a dormant autoimmune condition (e.g., Lupus or Rheumatoid Arthritis). This requires careful dosing and monitoring.
- History of Cancer (Remission): If you are 5+ years cancer-free, you are in a gray area. Use is not strictly forbidden, but the risk profile is higher than the general population. Non-growth peptides might be acceptable, but GH pathways remain high-risk.
- Psychiatric History: Some peptides (like Melanotan II) have been linked to mood changes or anxiety. Patients with a history of severe anxiety or bipolar disorder should monitor their mental state closely, as neurochemical shifts can occur.
